INTRODUCTION
Hepatitis C virus (HCV) is a major global cause of liver disease, with 350 000 people dying every year from hepatitis C-related disease. 1 HCV is primarily spread through contact with infected blood, leading to chronic infection in 80% of infected individuals. More than half of these chronically infected individuals develop chronic liver disease, including cirrhosis and hepatocellular carcinoma. Twenty percent of individuals spontaneously clear the virus without treatment.
There are marked racial differences in HCV outcomes. In the United States, overall HCV prevalence is more than doubled in African Americans (3.2%) compared with non-Hispanic whites (1.5%). 2 In addition, among those exposed to HCV infection, viral persistence is fivefold more common among persons of African compared with European descent. 1, 3 African Americans also respond worse to interferon-based treatments for HCV infection. 2, 4 In contrast, when compared with European Americans, African Americans are less likely to progress to cirrhosis. 5, 6 While viral or environmental factors may contribute, these marked divergent clinical outcomes in persons of African compared with European descent suggest a role for host genetics.
Previous human genetic studies have identified susceptibility loci for spontaneous resolution of HCV. The most consistent genetic association has been with variants near IL28B (interleukin-28B), now IFNL3, 7, 8 and the major histocompatibility complex (MHC) region, specifically with human leukocyte antigen class II. 9 Recent genome-wide association studies have identified upstream IL28B variants rs12979860 and rs8099917 to be consistently associated with spontaneous HCV clearance (odds ratio (OR) ¼ 0.45, 0.43). 7, 9 The single-nucleotide polymorphism (SNP) rs12979860 may explain nearly half of the difference in spontaneous clearance rates between African and European Americans, as demonstrated by a conditional analysis. 9 A recent study found a frameshift mutation, ss496415590, in high linkage disequilibrium with rs12979860 that creates a new gene that is similar to IL28B, and stimulates similar cellular pathways. 10 Candidate gene studies have also identified genetic associations with spontaneous HCV clearance in HAVCR1, TNFSF18, TANK and IL18BP.
11 However, these variants do not fully explain the difference in HCV resolution between individuals of European and African ancestry.
These differences in outcomes of HCV infection between European and African Americans make it an ideal candidate for admixture mapping, which estimates the degree to which an individual's genome is of African and European origin. 12 When two distinct continental populations mix, in this case Europe and Africa, the resulting population is admixed. After successive generations of mixing, blocks of the genome are inherited intact due to patterns of linkage disequilibrium. These chromosomal segments retain the same structure as their European or African ancestors. An admixed individual's genomic segment that is African or European in origin, or their 'local ancestry', can then be estimated across the genome. At any given locus, an individual will have 0, 1 or 2 haplotype segments of European/African ancestry. Admixture mapping uses these measures of local ancestry to evaluate differences in phenotype among individuals. The main hypothesis of this study is that some alleles associated with HCV spontaneous clearance or persistence may be more prevalent in individuals with higher local African ancestry compared with European ancestry. Using genome-wide admixture mapping, we tested this hypothesis with 473 individuals of African descent from 7 studies using 792 721 markers to examine associations between local ancestry and HCV spontaneous clearance. Figure 1) . Local ancestry was estimated at 792 721 SNP locations genome-wide using the statistical program LAMP-LD (Local Ancestry in adMixed Populations) 13 ( Figure 1 ).
RESULTS
Each location is represented by a single SNP. The average African ancestry proportion across the genome was 79.49%, which is consistent with prior estimates of African ancestry for African Americans. 14, 15 Local ancestry estimates were analyzed for association with spontaneous clearance versus chronic or persistent infection of HCV using an unadjusted simple model of logistic regression. Local ancestry was represented in an additive format, with individuals having 0, 1 or 2 haplotype segments of African ancestry for each location on the genome-wide SNP array. The strongest association with local African ancestry occurred at 15q24 (P ¼ 3.19 Â 10 À 4 ) ( Figure 2 ) with additional signals occurring at 1p31.1 (P ¼ 8.43 Â 10 À 4 ) and 20p12 (P ¼ 8.68 Â 10 À 4 ) ( Table 2 ). The 15q24 and 20p12 regions were confirmed using an alternative method (Po0.01). Each SNP location within these two regions was further analyzed in an extended model logistic regression that assessed the association of local ancestry in an additive format, controlling for HIV status and genotype (0, 1 or 2 copies of the SNP's minor allele) ( Table 2 ). This extended model controls for signals due to a single ancestry-informative marker, while improving the resolution and significance of the findings.
The strongest signal on chromosome 20 for the association of local ancestry with spontaneous clearance using the unadjusted model was in a 36.87-kilobase (kb) region on 20p12. Figure 2) . This region is within the gene serine palmitoyltransferase long chain base subunit 3 (SPTLC3). When this region was adjusted for HIV status and local genotype in the extended logistic regression model, the strongest local ancestry association localized within an intronic region of SPTLC3. For each copy of the African ancestral haplotype there is a twofold increased association with HCV spontaneous clearance (OR ¼ 2.07,
). Within the extended model adjusting for local ancestry and HIV status, the local genotype at this location (SNP rs6041855) was not significant (P ¼ 0.05). Although the mean African ancestry at this location was 79.37%, consistent with the genome-wide average (79.49%), the cases with HCV spontaneous clearance had higher African ancestry (85.31%), while the controls with HCV persistent infection had lower African ancestry (75.84%) (P ¼ 0.019).
An additional local ancestry association signal from the unadjusted model was identified for a 63.95-kb region on 20p12.3 within the gene PLCB1, phospholipase C beta 1 (P ¼ 8.86
). Adjusted for HIV status and local genotype in the extended model, the strongest local ancestry association within this region was found in an intronic region of PLCB1 (OR ¼ 2.09,
). For every additional ancestral African haplotype at this location, an individual had 2 times the odds of clearance. The local ancestry signal in this region was independent of both rs4273729 (human leukocyte antigen class II) and rs12979860 (IL28B). The SNP at this location, rs6086518, was not significantly associated (P ¼ 0.01). No genome-wide significant SNPs were ) after imputation in either of the chromosome 20 regions.
Genome-wide, the strongest association of local ancestry using the simple model was a 216.12-kb region on 15q24 (P ¼ 3.19 Â 10 Figure 3) . This region contained five different genes (C15orf27, ETFA, TYRO3P, ISL2 and SCAPER), and was centered over ETFA. After adjustment for HIV status and genotype in the extended model logistic regression, the strongest local ancestry association lay within RCN2 (OR ¼ 2.23, P ¼ 2.26 Â 10 À 5 ), a gene next to SCAPER. The local ancestry signal in this region was independent of both human leukocyte antigen class II and IL28B variants (P40.05) as assessed by interaction analyses using logistic regression. The genotyped SNP at this location, rs15939, did not reach genome-wide significance (P ¼ 0.004) with HCV clearance. We imputed SNPs across this region using 1000 Genomes as a reference, identifying a genome-wide significantly associated Figure 2 . Genome-wide results for association of local ancestry with spontaneous clearance versus chronic infection of HCV by chromosome (x axis). Significance is indicated by the y axis using the À log 10 P-value. Abbreviation: HCV, Hepatitis C virus. The top association within the simple model using an unadjusted logistic regression on local ancestry estimates is denoted simple. The extended label is the top 10 associations in that same region, using the extended model of logistic regression on local ancestry estimates, adjusting for HIV status and genotype.
SNP between SCAPER and RCN2 at rs55817928 (OR ¼ 2.38,
), which conferred more than twice the odds of spontaneous clearance with every ancestral allele (Figure 3) . The major allele (C), which was associated with clearance, is found in lower frequencies within European populations (40%) than within African populations (76%). This is consistent with African ancestry being associated with spontaneous clearance in this region. Conditioning on the minor allele of this SNP attenuated the local ancestry signal in this region below 10 À 2 (Figure 4) , suggesting that rs55817928, or likely a variant in strong linkage disequilibrium to this SNP, is largely responsible for the local ancestry association in this location.
Using Phase II data from the International HapMap, 16 measures of selection were determined using Haplotter, 17 which maps the integrated haplotype score (iHS), a measure of positive selection that examines extended homozygosity of haplotypes around a positively selected allele. 17 An iHS of 42 indicates that the haplotypes on the ancestral allele are longer compared with the derived allele and an iHS of o À 2 indicates that the haplotypes are longer on the derived allele compared with the ancestral allele. We expect the region around a derived (non-ancestral) allele that emerged under strong selection to have higher haplotype homozygosity than a neutral model, and this is reflected in the iHS. An iHS can be standardized by other locations with the same derived (non-ancestral) allele frequency.
Both regions on chromosomes 15 and 20 contain evidence for selection, specifically in the Yoruba (YRI), a Nigerian population. 
DISCUSSION
We used admixture mapping to identify two regions, 20p12.3 (SPTLC3) and 15q24 (SCAPER, RCN) that were suggestive of African descent conferring a higher odds of spontaneous clearance compared with European descent. This is surprising, as African Americans clear the virus at a much lower rate than European Americans. Our findings highlight specific regions that may reveal a more complex picture of genetic susceptibility to HCV chronic infection. Measures of selection in the Yoruba in Nigeria show evidence for selection in these two regions that are absent in European populations. Although unlikely that HCV has exerted this selective pressure since infection typically occurs later in life and does not alter reproduction, the selective pressures and resulting variants in these regions are associated with clearance of HCV among those who should have been predisposed to chronic infection. This mutation on an ancestral African haplotype may allow individuals to spontaneously clear the virus, despite the virus having evolved to persist as an asymptomatic infection.
There is a potential biological basis for these findings. The associated region on chromosome 20 is in SPTLC3. This gene is an isoform of the third component of serine palmitoyltransferase (SPT). SPT is responsible for the formation of ceramide from palmitoyl-CoA and serine. 18 This gene was previously implicated in the circulating levels of sphingolipid concentrations. 19 Prior molecular evidence points to the importance of sphingolipids, SPTLC3, and chronic HCV infection. 20 Use of a hepatotropic SPT inhibitor, NA808, was found to suppress HCV-RNA production, also interfered with sphingolipid metabolism. SPTLC3, when overexpressed, resulted in a two-to three-fold increase in the expression of SPT. This gene is expressed only in the liver and is involved in the rate-limiting step of de novo synthesis of sphingomyelin and ceramide. 21 Decreased SPT activity results in decreased levels of ceramide in the liver, which in turn could affect HCV replication. 22 The most significant association was on chromosome 15 and the region includes the gene SCAPER, an S-phase Cyclin A. SCAPER expression is known to be cell cycle independent and it interacts with cyclin A as well as Cdk2. 23 HCV non-structural protein 5-B has been shown to interact with cyclin A2, the somatic form of cyclin A, for the propagation of HCV. 24 Because the top associated region on chromosome 15 is between SCAPER and RCN2, we must also consider the potential role of RCN2 (reticulocalbin 2, EF-hand calcium binding domain). A part of the EF-hand superfamily RCN2 contains conserved regions with similarity to a high-affinity Ca 2 þ binding motif. HCV proteins have been shown to induce oxidative stress-mediated Ca 2 þ homeostasis alterations. 25 Due to the biological plausibility of both genes, it is not possible to know which contributed to the signal detected in this analysis.
This analysis was conducted in a relatively small sample size of African Americans, which could lead to spurious results. However, infectious diseases tend to have higher effect sizes than many chronic diseases due to selective pressures, so it is not surprising to see a significant association even with this smaller sample size. 26 By design, admixture mapping like linkage analysis has relatively low resolution and thus it is not feasible to identify causal alleles without additional sequencing of the regions. Future directions should include sequencing and phasing individuals of African descent in these regions to provide higher resolution of the underlying haplotypes. These findings highlight the potential role of African ancestry in chronic HCV infection.
MATERIALS AND METHODS

Study population and quality control
Individuals were selected from a previously published genome-wide association study (GWAS) of spontaneous HCV clearance. 9 A principal components analysis was conducted on the diverse study population using EIGENSTRAT, 27 and a subgroup of individuals of African descent was selected from the larger study. A total of 473 individuals were included in all further analyses. These individuals were drawn from seven different cohorts:
and WIHS (N ¼ 140). Cohort descriptions can be found in the previous publication of the GWAS. 9 Of these individuals, 177 had spontaneously cleared, while 296 remained persistently infected. These individuals have been screened for individual missingness o2%, heterozygosity within the range of the study population, as well as cryptic relatedness. Genotypic data had previously gone through standard GWAS quality control measures as well. SNPs were filtered for minor allele frequency 41%, genotypic missingness o5%, and Hardy-Weinberg Equilibrium P-value 410E À 5. A total of 792 721 SNPs were included for analysis.
Local admixture estimation
Local ancestry was estimated using LAMP-LD. 13 Each chromosome was estimated separately for all 473 individuals. Two populations were assumed, consistent with most individuals of mixed African ancestry. The 1000 Genomes Project's European (CEU, TSI, FIN, GBR and IBS) and African (YRI and LWK) populations were used as reference populations. Average African Ancestry was calculated by weighting each individual's chromosomal average by the number of markers used for that chromosome. These weighted chromosomal means were then averaged across all chromosomes.
ANCESTRYMAP
To confirm findings with another analytical program, ANCESTRYMAP 28 was used to estimate areas of the genome associated with clearance. Markers that are informative to the individual's ancestry were subsetted from the entire GWAS. These markers were drawn from a previously published high-density admixture map, 12 as well as a commercially available Illumina admixture panel (http://support.illumina.com/documents/MyIllumina/e5c 05695-bf53-4be8-85ab-f9612839dfdc/African_American_Admixture.zip). A total of 1748 SNPs were used in this analysis. A Markov Chain Monte Carlo run using 1000 burn-in and 2000 follow-up iterations was used. The Case Control Statistic, a modified t-statistic, was used to control for possible fluctuations in ancestry estimates that occurred in both the cases and the controls.
Association testing
Genome-wide association results were calculated for the association of local ancestry with spontaneous clearance. An additive logistic regression model was used within R. Signals that were consistent between ANCESTRYMAP and the associations of local ancestry were followed up. These included regions on chromosomes 5, 15 and 20. They were followed up with an additive logistic regression model, adjusted for the number of minor alleles (genotype) at that location, as well as individual HIV status. This provided a finer resolution to the association mapping. To control for small numbers, the top locus for each region was then followed up with a recessive model for local ancestry, and with a dominant model for the genotype. Results remained consistent. A possible interaction with IL28B risk variant rs12979860 was conducted by introducing an interaction term between the SNP and the local ancestry at the location of interest within a logistic regression model and evaluating for significance of the interaction term. This process was repeated for the human leukocyte antigen class II variant rs4273729. The conditional analysis with rs55817928 was conducted using a dominant model for the SNP, which was then used as a covariate with logistic regression in R.
Imputation
Imputation was conducted in the top regions including 73.5-75.5 Mb on chromosome 5, 76-78 Mb on chromosome 15 and 10-14 Mb on chromosome 20 using IMPUTE2 29 with a multi-ethnic reference panel from 1000G. Imputed genotypes were subjected to quality control measures, such as minor allele frequency 41%, and information content 480%. The chromosome 5 region had 448 genotyped SNPs and 5712 imputed SNPs that passed quality control. For the chromosome 15 region, there were 385 originally genotyped SNPs and 7656 imputed SNPs. Chromosome 20 region had 2366 genotyped SNPs and 27 170 imputed variants. Association testing was conducted using a Frequentist EM algorithm, and an additive model within SNPTEST V2 29 controlling for HIV status and the first principal component.
